UK centre seeks wider pre-implantation testing:
This article was originally published in Clinica
London's Bridge Fertility, Gynaecology and Genetics Centre is planning to apply for a licence to use isothermal whole genome amplification in pre-implantation testing. It says that the technique would enable it to screen for "hundreds of conditions" within days of fertilisation. At present, pre-implantation genetic screening, which is regulated by the Human Fertilisation and Embryology Authority (HFEA), can only be performed on a small number of disorders, such as cystic fibrosis, muscular dystrophy and haemophilia. "Centres must submit an application to the HFEA for each new condition for which they wish to test and for each new test that they wish to use," according to current HFEA guidelines, issued in 2001.